Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
Gangliosides are known as modulators of transmembrane signaling by regulating various receptor functions. We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. We also demonstrated that TNF-alpha simultaneously produced insulin resistance by uncoupling insulin receptor activity toward insulin receptor substrate-1 (IRS-1) and suppressing insulin-sensitive glucose transport. Pharmacological depletion of GM3 in adipocytes by an inhibitor of glucosylceramide synthase prevented the TNF-alpha-induced defect in insulin-dependent tyrosine phosphorylation of IRS-1 and also counteracted the TNF-alpha-induced serine phosphorylation of IRS-1. Moreover, when the adipocytes were incubated with exogenous GM3, suppression of tyrosine phosphorylation of insulin receptor and IRS-1 and glucose uptake in response to insulin stimulation was observed, demonstrating that GM3 itself is able to mimic the effects of TNF on insulin signaling. We used the obese Zucker fa/fa rat and ob/ob mouse, which are known to overproduce TNF-alpha mRNA in adipose tissues, as typical models of insulin resistance. We found that the levels of GM3 synthase mRNA in adipose tissues of these animals were significantly higher than in their lean counterparts. Taken together, the increased synthesis of cellular GM3 by TNF may participate in the pathological conditions of insulin resistance in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [523]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Research works printed but not linked: 4
- Moller, 1992, N. Engl. J. Med., 325, 938
- Radin, 1993, Adv. Lipid Res., 26, 183
- Tanaka, 1994, 76, 374
- Engelman, 2000, Mol. Endocrinol., 14, 1557
Cited by
Items 301–357 of 357
Viral Protein Interaction with Host Cells GSLs
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5807-8_4 · Cited by 2
Kolyovska, V., Ivanova, S., Drenska, D., Maslarov, D. B., & Toshkova, R. A. (2021) · Biocell · doi:10.32604/biocell.2021.016250 · Cited by 2
“GM3 and diabetes mellitus The increased titers of IgG anti-GM3 antibodies are related to the development of insulin resistance, and thus, the GM3 has been supposed to participate in the pathogenesis of diabetes (Inokuchi, 2014; Kabayama et al., 2007; Lipina and Hundal, 2015; Tagami et al., 2002).”
BackgroundSialidase-Resistant Ganglioside GM3 Analogues: Evaluation of Biological Activity
Hirai, G. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2910-9_7 · Cited by 2
Inokuchi, J., Kabayama, K., Sato, T., & Igarashi, Y. (2006) · Springer eBooks · doi:10.1007/4-431-34200-1_21 · Cited by 4
“We extended these in vitro observations to living animals using obese Zucker fa/fa rats and ob/ob mice, in which the GM3 synthase mRNA levels in the white adipose tissues are significantly higher than in their lean controls (Tagami et al., 2002).”
MethodSelf-citationPeng, X., Li, H., Wang, Q., Wang, P. G., & Ji, Y. (2025) · Biomolecules · doi:10.3390/biom15111522 · Cited by 2
“These changes are consistent with findings in mouse models, where GM3 induced by inflammatory cytokines such as TNF-α has been shown to impair insulin signaling [39].”
PAQ receptors: a counteracting force to ceramides?
Holland, W. L., & Scherer, P. E. (2009) · Cited by 1
The Regulation of Ganglioside GM3 Synthesis
Uemura, S. (2012) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.132.895 · Cited by 2
Self-citationГеоргиевна, Б. И., Skurygin, V. V., & Protopopov, V. A. (2024) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s002209302402011x · Cited by 1
“At the same time, ganglioside GM3 displays an inhibitory effect on insulin sensitivity in the myotubes [56].”
Lipid Mediators in Metabolic Syndrome and Neurological Disorders
Farooqui, A. A. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7318-3_4 · Cited by 1
Sphingolipid mediators of cell signaling and metabolism
Dobrzyń, A., Janikiewicz, J., Tracz‐Gaszewska, Z., Filip, A., Dobosz, A. M., Krogulec, E., & Dobrzyń, P. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819404-1.00019-1 · Cited by 1
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5807-8_3 · Cited by 1
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5815-3_8 · Cited by 1
Lipidomics for Elucidation of Metabolic Syndrome and Related Lipid Metabolic Disorder
Taguchi, R., Ikeda, K., & Nakanishi, H. (2012) · Wiley eBooks · doi:10.1002/9783527655946.ch12 · Cited by 1
Insulin Resistance and Type 2 Diabetes as Microdomain Disease: Implication of Ganglioside GM3
Inokuchi, J., & Kabayama, K. (2009) · Springer eBooks · doi:10.1007/978-4-431-77922-3_78 · Cited by 1
“We demonstrated that increased GM3 expression was accompanied in the state of insulin resistance in mouse 3T3-L1 adipocytes induced by TNFα and in the adipose tissues of obese/diabetic rodent models such as Zucker fa/fa rats and ob/ob mice ( Tagami et al. 2002 ).”
BackgroundSelf-citationEditorial: Bioactive sphingolipids in health and disease
Aslan, M., Öztaş, Y., & Silva, L. C. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1051449 · Cited by 1
“Expression patterns of GM3 ganglioside vary during pathogenesis of metabolic syndrome (Tagami et al., 2002).”
BackgroundLysosomale Speicherkrankheiten
Herold, G. (2022) · De Gruyter eBooks · doi:10.1515/9783111078304-020 · Cited by 1
GM3 Synthase (ST3Gal5) and Diabetes
Inokuchi, J.-I. (2014) · Springer eBooks · doi:10.1007/978-4-431-54841-6_210
Self-citationGlycosphingolipids in HIV/AIDS: The Potential Therapeutic Application
Clifford, A., & Donald, R. (2011) · InTech eBooks · doi:10.5772/21134
“GM3 interaction with the insulin receptor is important in type 2 diabetes (Tagami et al., 2002, van Eijk et al., 2009).”
BackgroundInsulin sensitivity of hepatic glucose and lipid metabolism in animal models of hepatic steatosis
Grefhorst, A. (2006) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Studies on the role of glycosphingolipids in metabolism
Langeveld, M. (2009) · UvA-DARE (University of Amsterdam) · Cited by 1
Membrane microdomain malfunction and insulin resistance in type 2 diabetes
Inokuchi, J. (2005) · Colloids and Surfaces A Physicochemical and Engineering Aspects · doi:10.1016/j.colsurfa.2005.11.034
Self-citationKwak, D. H., Lee, S. D., Lee, J.-H., Kim, J.-S., Kim, S., Chang, K., & Choo, Y. (2014) · Animal Cells and Systems · doi:10.1080/19768354.2014.975279
Involvement of membrane microdomains in the pathogenesis of metabolic syndrome and asthma
Inokuchi, J. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.05.055
Self-citationBiological function of glycosphingolipids —mouse early stage development and neuronal function—
Yamashita, T. (2009) · Trends in Glycoscience and Glycotechnology · doi:10.4052/tigg.21.290
Glycosphingolipids and atherosclerosis
Lombardo, E. (2013) · UvA-DARE (University of Amsterdam)
Inokuchi, J. (2014) · Springer eBooks · doi:10.1007/978-4-431-55381-6_14
Self-citationSphingolipids in essential hypertension and endothelial dysfunction
Spijkers, L. J. A. (2013) · UvA-DARE (University of Amsterdam)
Disorder:Involvement of Ganglioside GM3
Kabayama, K., Sato, T., Kitamura, F., Uemura, S., Kang, B. W., Igarashi, Y., & Inokuchi, J. (2004)
Self-citation4 Lysosomale Speicherkrankheiten
Stulnig, T. (2004) · Thieme eBooks · doi:10.1055/b-0034-13057
Analysis of electrostatic interaction between ganglioside GM3 and transmembrane peptide
Nimura, Y., Kabayama, K., Asahina, Y., Hanashima, S., Hojo, H., Murata, M., & Fukase, K. (2019) · AIP conference proceedings · doi:10.1063/1.5089453
Self-citationInsulin resistance and obesity
Farooqui, A. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819603-8.00001-8 · Cited by 1
GM3, Caveolin-1 and Insulin Receptor in Insulin Resistance
Kim, C. (2020) · Springer eBooks · doi:10.1007/978-981-15-5652-4_18
ガングリオシドのアシル鎖構造によるToll-like receptor 4活性化制御メカニズム
裕考, 狩., 昂大, 新., 藤居真優, 樺山一哉, 敦史, 下., 浩一, 深., Sonnino, S., 明身, 鈴., & 仁一, 井. (2019) · doi:10.24753/jeiis.22.0_1
Ishikawa, T. (2020) · KAGAKU TO SEIBUTSU · doi:10.1271/kagakutoseibutsu.58.659
Kanoh, H. (2022) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.21-00193
Participación potencial del sistema inmunitario adaptativo en el desarrollo de neuropatía diabética
Cifuentes‐Mendiola, S. E., García‐Hernández, A. L., & Pérez-Martínez, I. O. (2022) · Alad · doi:10.24875/alad.21000015
Lipid antigens in adipose tissue: A CD1d centered view on adipocyte - iNKT cell communication
van Eijkeren, R. J. (2022) · Utrecht University Repository (Utrecht University) · doi:10.33540/1201
Amino acids and mammalian target of rapamycin-dependent signalling
Meijer, A. J., Dubbelhuis, P. F., & Houben-Weerts, J. H. P. M. (2007) · Springer eBooks · doi:10.1007/1-4020-4456-9_27
Lysosomale Speicherkrankheiten
(2012) · Thieme eBooks · doi:10.1055/b-0034-10439
GM3 Synthase (ST3Gal5) and Diabetes
Inokuchi, J. (2014) · Springer eBooks · doi:10.1007/978-4-431-54836-2_210-1
Self-citation38.2 Lysosomale Speicherkrankheiten
(2010) · Thieme eBooks · doi:10.1055/b-0034-86112
Masson, E. (2005) · OpenGrey (Institut de l'Information Scientifique et Technique)
Sainova, I. V., Kolyovska, V., Drenska, D., Maslarov, D. B., Petrov, A., Dimitrova-Dikanarova, D. K., & Markova, T. (2024) · Pharmacia · doi:10.3897/pharmacia.71.e138022
“In this regard, the accumulation of GM3 ganglioside has been suggested as one of the main causes for the disruption of signaling interactions also involving insulin, which often leads to the emergence of insulin resistance (Tagami et al. 2002; Kabayama et al. 2005; Kabayama et al. 2007).”
BackgroundLiu, F., Liu, Y., Liu, H., Zhang, J., Xu, J., Sollogoub, M., & Zhang, Y. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01242 · Cited by 1
Grassi, S., Prioni, S., Marchesini, A., Cappelletti, G., & Prinetti, A. (2026) · Neurochemical Research · doi:10.1007/s11064-025-04657-8
“…phosphorylation and dimerization are inhibited by GM3, but uninfluenced by GM1 [ 14 ], and by insulin receptor, inhibited by GM3 but not GD1a [ 15]. rHIgM22 effects on sphingolipid patterns were specific to cells of the oligodendrocyte lineage. rHIgM22 did not affect sphingolipid metabolism…”
Effet de l’expression de la GD3 synthétase sur la progression et l’agressivité du cancer du sein
Cazet, A. (2010) · theses.fr (ABES) · doi:10.70675/db7f2cc7zc960z4010z9c7bzbc4b5ba2c685
Rusciani, A. (2012) · theses.fr (ABES) · doi:10.70675/7850a963z0823z4a4ezae90ze96b025fd66e · Cited by 1
Homéostasie des céramides et hépatopathies métaboliques
Régnier, M. (2018) · theses.fr (ABES) · doi:10.70675/2fb92711z373cz4b27z8082z7aa3f8930e63 · Cited by 1
Mansueto, A. J., Norris, A. C., Yazlovitskaya, E. M., Zhu, L., Lu, J., Koomen, D. C., May, J. C., Kim, M., Hermanson, J. N., Molday, R. S., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-57906-3
Electrostatic Interaction Analysis Between GM3 and Insulin Receptor
Kabayama, K. (2026) · Methods in molecular biology · doi:10.1007/978-1-0716-5288-6_14
Self-citationNEU3 at the plasma membrane: context-dependent ganglioside remodeling in health and disease
Cirillo, F., Rota, P., Anastasia, L., & Piccoli, M. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101175
BindingDB (2013) · UC San Diego · doi:10.7270/q2mg7qmf
BindingDB Entry 50034057: Discovery of a new class of glucosylceramide synthase inhibitors.
BindingDB (2012) · UC San Diego · doi:10.7270/q2833sg2
Metadata
- Authors
- Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., Sakaue, S., & Igarashi, Y.
- Affiliations
- Hokkaido University (JP)
- National Cancer Centre Japan (JP)
- Corresponding author
- Inokuchi, Jin-ichi
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3085-3092
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157934599
- Cited by
- 355
- References
- 62
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 16 · 2021: 14 · 2020: 27 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 23 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6818 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- GM3 ganglioside, insulin resistance, TNF-α, GM3 synthase, IRS-1, IRS-1 serine phosphorylation, insulin receptor tyrosine phosphorylation, glucose transport, adipocytes, type 2 diabetes, obesity, glucosylceramide synthase inhibition, 3T3-L1 adipocytes, Zucker fatty rats, ob/ob mice
- MeSH terms
- Animals, Cell Differentiation, Enzyme Inhibitors, G(M3) Ganglioside, Glucosyltransferases, Insulin, Insulin Resistance, Mice, Obese, Rats, Zucker, Sialyltransferases, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, 3T3 Cells, Adipocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.